share_log

Option Care Health (NASDAQ:OPCH) Shares Gap Up to $30.38

Option Care Health (NASDAQ:OPCH) Shares Gap Up to $30.38

期权医疗保健(纳斯达克:OPCH)股价差距高达30.38美元
Defense World ·  2023/01/01 01:51

Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) gapped up prior to trading on Friday . The stock had previously closed at $30.38, but opened at $31.05. Option Care Health shares last traded at $30.16, with a volume of 561 shares changing hands.

期权护理健康公司(纳斯达克:OPCH-GET评级)在周五交易前出现缺口。该股此前收盘报30.38美元,开盘报31.05美元。Option Care Health股票尾盘报30.16美元,成交量为561股。

Analyst Ratings Changes

分析师评级发生变化

Separately, Barrington Research lifted their price objective on Option Care Health from $37.00 to $38.00 and gave the company an "outperform" rating in a report on Friday, October 28th.

另外,Barrington Research在10月28日星期五的一份报告中将Option Care Health的价格目标从37.00美元上调至38.00美元,并给予该公司“跑赢大盘”的评级。

Get
到达
Option Care Health
Option Care Health
alerts:
警报:

Option Care Health Stock Performance

期权医疗保健股票表现

The company has a 50 day moving average price of $30.25 and a 200-day moving average price of $31.11. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.79. The company has a market cap of $5.47 billion, a P/E ratio of 30.70, a price-to-earnings-growth ratio of 2.83 and a beta of 1.19.

该公司的50日移动均线价格为30.25美元,200日移动均线价格为31.11美元。该公司的流动比率为1.62,速动比率为1.22,债务权益比率为0.79。该公司市值为54.7亿美元,市盈率为30.70倍,市盈率为2.83倍,贝塔系数为1.19。

Option Care Health (NASDAQ:OPCH – Get Rating) last issued its quarterly earnings results on Thursday, October 27th. The company reported $0.21 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.21. Option Care Health had a return on equity of 11.80% and a net margin of 4.64%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $994.38 million. On average, equities analysts expect that Option Care Health, Inc. will post 0.79 earnings per share for the current fiscal year.
Options Care Health(纳斯达克代码:OPCH-GET Rating)最近一次发布季度收益报告是在10月27日(星期四)。该公司公布本季度每股收益(EPS)为0.21美元,符合市场普遍预期的0.21美元。Option Care Health的股本回报率为11.80%,净利润率为4.64%。该公司本季度营收为10.2亿美元,而分析师预期为9.9438亿美元。股票分析师平均预计,期权Care Health,Inc.本财年的每股收益将为0.79美元。

Insider Activity

内幕活动

In related news, Director R Carter Pate sold 1,928 shares of the business's stock in a transaction on Monday, October 3rd. The stock was sold at an average price of $31.97, for a total transaction of $61,638.16. Following the sale, the director now owns 95,530 shares in the company, valued at approximately $3,054,094.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.22% of the company's stock.

在相关新闻中,董事R卡特·佩特在10月3日星期一的一次交易中出售了1,928股该公司的股票。该股以31.97美元的平均价格出售,总成交金额为61638.16美元。交易完成后,董事现在拥有该公司95,530股股份,价值约3,054,094.10美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可在此超链接。企业内部人士持有该公司0.22%的股票。

Institutional Investors Weigh In On Option Care Health

机构投资者参与期权医疗保健

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. FMR LLC grew its position in Option Care Health by 4.9% during the 2nd quarter. FMR LLC now owns 19,738,359 shares of the company's stock worth $548,530,000 after acquiring an additional 918,277 shares during the last quarter. BlackRock Inc. grew its position in Option Care Health by 20.7% during the 3rd quarter. BlackRock Inc. now owns 19,187,400 shares of the company's stock worth $603,829,000 after acquiring an additional 3,290,272 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Option Care Health by 8.1% in the 3rd quarter. Vanguard Group Inc. now owns 15,269,619 shares of the company's stock valued at $480,534,000 after buying an additional 1,147,767 shares during the last quarter. Marshall Wace LLP grew its position in shares of Option Care Health by 27.1% in the 3rd quarter. Marshall Wace LLP now owns 5,000,053 shares of the company's stock valued at $157,355,000 after buying an additional 1,066,480 shares during the last quarter. Finally, State Street Corp grew its position in shares of Option Care Health by 8.2% in the 3rd quarter. State Street Corp now owns 4,841,602 shares of the company's stock valued at $152,365,000 after buying an additional 365,213 shares during the last quarter. Institutional investors own 97.63% of the company's stock.

一些对冲基金和其他机构投资者最近买卖了该公司的股票。第二季度,FMR LLC在Option Care Health的头寸增加了4.9%。FMR LLC在上个季度额外收购了918,277股后,现在拥有该公司19,738,359股股票,价值548,530,000美元。第三季度,贝莱德公司在Option Care Health的地位增长了20.7%。贝莱德股份有限公司在上个季度增持了3,290,272股后,现在持有19,187,400股该公司股票,价值603,829,000美元。先锋集团(Vanguard Group Inc.)第三季度将其在Option Care Health的股票头寸增加了8.1%。先锋集团目前持有15,269,619股该公司股票,价值480,534,000美元,上一季度又购买了1,147,767股。马歇尔·华斯有限责任公司在第三季度将其在Option Care Health的股票头寸增加了27.1%。马歇尔·华斯有限责任公司在上个季度又购买了1,066,480股后,现在拥有5,000,053股该公司股票,价值157,355,000美元。最后,道富银行在第三季度将其在Option Care Health的股票头寸增加了8.2%。道富银行目前持有该公司4,841,602股股票,价值152,365,000美元,此前该公司在上一季度又购买了365,213股。机构投资者持有该公司97.63%的股份。

About Option Care Health

关于Option Care Health

(Get Rating)

(获取评级)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Option Care Health,Inc.在美国提供家庭和备用地点输液服务。该公司提供抗感染治疗;治疗心力衰竭的家庭输液服务;治疗中风、癌症和胃肠道疾病等多种急慢性疾病的家庭非肠道营养和肠内营养支持服务;治疗免疫缺陷的免疫球蛋白输注疗法;以及治疗慢性炎症性疾病的治疗,包括克罗恩病、斑块状牛皮癣、牛皮癣关节炎、类风湿性关节炎、溃疡性结肠炎和其他慢性炎症性疾病。

Read More

阅读更多内容

  • Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
  • MarketBeat: Week in Review 12/26 – 12/30
  • The Dogs Of Tech: It's Time For A Bite Of These Stocks
  • Does This Acquisition Make Microsoft a Bear Market Buy?
  • Should You Warm up to Generac Stock for the Winter?
  • Is Kintara Therapeutics A Hidden Gem?
  • 免费获取StockNews.com关于选项护理健康(OPCH)的研究报告
  • MarketBeat:回顾一周12/26-12/30
  • 科技狗:是时候咬一口这些股票了
  • 这笔收购会让微软成为熊市买入者吗?
  • 你应该热身到Generac股票过冬吗?
  • 金塔拉治疗公司是一颗隐藏的宝石吗?

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.

接受《每日健康选择》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯,接收对Option Care Health和相关公司的最新新闻和分析师评级的简要每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发